UBS Maintains Buy on Cardinal Health, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Buy rating on Cardinal Health (NYSE:CAH) and raises the price target from $120 to $125.
August 15, 2024 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Caliendo maintains a Buy rating on Cardinal Health and raises the price target from $120 to $125.
The Buy rating and increased price target from a reputable analyst at UBS is likely to positively impact Cardinal Health's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100